These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4881892)

  • 21. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

  • 22. Alternate-day corticosteroid regimen.
    Haim S; Benderly A; Shafrir A; Levy J
    Dermatologica; 1971; 142(3):171-6. PubMed ID: 5112615
    [No Abstract]   [Full Text] [Related]  

  • 23. Cushing's syndrome: a prospective study of diagnostic methods.
    Eddy RL; Jones AL; Gilliland PF; Ibarra JD; Thompson JQ; MacMurry JF
    Am J Med; 1973 Nov; 55(5):621-30. PubMed ID: 4749204
    [No Abstract]   [Full Text] [Related]  

  • 24. Exacerbation of Cushing's syndrome during pregnancy: report of a case.
    Calodney L; Eaton RP; Black W; Cohn F
    J Clin Endocrinol Metab; 1973 Jan; 36(1):81-6. PubMed ID: 4344310
    [No Abstract]   [Full Text] [Related]  

  • 25. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol-induced pseudo-Cushing's syndrome.
    Jeffcoate W
    Lancet; 1993 Mar; 341(8846):676-7. PubMed ID: 8095582
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reduced pyruvate tolerance in Cushing's syndrome].
    Massara F; Camanni F; Molinatti GM
    Folia Endocrinol; 1966 Jun; 19(3):368-77. PubMed ID: 6012945
    [No Abstract]   [Full Text] [Related]  

  • 28. [Infantile cushing's disease with paradoxical response to dexamethasona due to a probable periodic hormogenesis (author's transl)].
    Martul P; Loridan L; Igea J; Luzuriaga C
    An Esp Pediatr; 1978 Mar; 11(3):213-8. PubMed ID: 666127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of urinary excretion of steroids in Cushing's syndrome.
    Martin MM; Hamman BL
    J Clin Endocrinol Metab; 1966 Mar; 26(3):257-67. PubMed ID: 4286016
    [No Abstract]   [Full Text] [Related]  

  • 30. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate.
    Malik KJ; Wakelin K; Dean S; Cove DH; Wood PJ
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():187-9. PubMed ID: 8791979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cushing's syndrome and adrenal gland depression caused by intranasal spray containing dexamethasone in 2 siblings].
    Varotti C; Passarini B; Pasquali R
    G Ital Dermatol Venereol; 1987 Mar; 122(3):121-3. PubMed ID: 3596646
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 33. The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Sep; 2(8506):540-4. PubMed ID: 2875282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of betamethasone on the pituitary-adrenal system].
    Kasperlik-Zaluska A; Midgalska B
    Endokrynol Pol; 1966; 17(6):753-6. PubMed ID: 5978262
    [No Abstract]   [Full Text] [Related]  

  • 35. Apparently normal pituitary-adrenal suppressibility in Cushing's syndrome: dexamethasone metabolism and plasma levels.
    Meikle AW; Lagerquist LG; Tyler FH
    J Lab Clin Med; 1975 Sep; 86(3):472-8. PubMed ID: 1151162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical findings and laboratory diagnosis in Cushing's syndrome].
    Staub JJ; Philbert M; Luton JP; Bricaire H
    Praxis; 1968 Oct; 57(41):1398-409. PubMed ID: 4307489
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid dexamethasone suppression test for Cushing's syndrome.
    Tucci JR; Jagger PI; Lauler DP; Thorn GW
    JAMA; 1967 Feb; 199(6):379-82. PubMed ID: 5334596
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 39. Overnight suppression test with dexamethasone in Cushing's syndrome.
    Sawin CT; Bray GA; Idelson BA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):422-4. PubMed ID: 4868264
    [No Abstract]   [Full Text] [Related]  

  • 40. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.